Here are the 2 spreads I did for New You magazine. The first article focus on combating caner with new integrative treatments while the second talks about the importance of caring for body, soul and mind.
An engineered herpesvirus that provokes an immune response against
cancer has become the first treatment of its kind to be approved for use
in the United States, paving the way for a long-awaited class of
therapies. On 27 October, the US Food and Drug Administration (FDA)
approved a genetically engineered virus called talimogene laherparepvec
(T-VEC) to treat advanced melanoma. Four days earlier, advisers to the
European Medicines Agency had endorsed the drug.
dozens of ongoing clinical trials of similar ‘oncolytic’ viruses,
researchers hope that the approval will generate the enthusiasm and cash
needed to spur further development of the approach. “The era of the
oncolytic virus is probably here,” says Stephen Russell, a cancer
researcher and haematologist at the Mayo Clinic in Rochester, Minnesota.
“I expect to see a great deal happening over the next few years.”
(29 October 2015)
Killer T cells (orange) are recruited to attack malignant cells (mauve) in the viral-based cancer therapy T-VEC. Dr. Andrejs Liepins/SPL
One-year-old Layla Richards was going to die. It was June
2015, and an extremely aggressive cancer called acute lymphoblastic
leukemia had charged through her body, despite traditional treatments
like a bone marrow transplant and chemotherapy. With no other recourse,
Richards was given a vial of genetically engineered cells that would,
hypothetically, kill the cancer.
Months later, she was in remission. Today, she continues to live healthily at home with her parents in the U.K. It’s the first success of its kind in the field: Human leukemia was killed by lab-engineered immune cells. How it works and what’s standing in the way.
Hello, my name is Monroe and my mother, Rhonda, was recently diagnosed with grade three breast cancer and she will have to undergo a double mastectomy and a hysterectomy, as well as chemotherapy and radiation. She will not be able to work during all of the treatment and surgeries and subsequent healing times, so we are hoping to help raise money for her to keep her bills paid and for basic expenses. The situation is very stressful and heartbreaking and I hope that people find it in their hearts to help out, as she has children and grandchildren living with her and money is tight as it is! Every dollar will truly count, and so will helping share this in hopes that others out there can see it and keep it boosting!!! Thank you everyone!!
In case you weren’t aware, I was recently diagnosed with Lymphoma. Unfortunately, due to this illness, my family and myself have incurred some financial burdens due to cancer treatment and lack of income from missing work. I’m hoping to raise some money to lessen this burden on me and my family. Please read the page, and please PLEASE reblog it so everybody can see! Every dollar helps.
Jell-O-like Substance Attracts, Kills Cancer Cells
Chasing cancer cells with chemotherapy drugs can save lives, but there’s no guarantee that the treatment will kill every run-away cancer cell in the body.
What if, instead of hunting those metastatic cells, a treatment could lure them out of hiding — every last one of them — and eliminate them in one swift blow? Yong Wang, associate professor of bioengineering at Penn State, has created such a therapy — a tissue-like biomaterial that attracts cancer cells, like bits of metal to a magnet, and entraps them.
A drug that’s already approved for treating leukemia appears to dramatically reduce symptoms in people who have Parkinson’s disease with dementia, or a related condition called Lewy body dementia.
A pilot study of 12 patients given small doses of nilotinib found that movement and mental function improved in all of the 11 people who completed the six-month trial, researchers reported Saturday at the Society for Neuroscience meeting in Chicago.
And for several patients the improvements were dramatic, says Fernando Pagan, an author of the study and director of the Movement Disorders Program at Georgetown University Medical Center. One woman regained the ability to feed herself, one man was able to stop using a walker, and three previously nonverbal patients began speaking again, Pagan says.
“After 25 years in Parkinson’s disease research, this is the most excited I’ve ever been,” Pagan says.
Please fire me. I work at the front desk of a pediatrician’s office. Today, I received a panicked phone call from the parent of a 7 year old who has “been around his grandfather who is currently going through chemo.” When I asked the parent why she felt the need to bring the child into the office for a visit for simply being around a chemo patient? “Well, I’m scared my child is catching the side effects of the chemo.”
Goodness gracious, great balls of cancer-killing poison. Researchers from the Houston Methodist Research Institute in Texas have
found a way to inject nanoparticles full of poison into metastases, or
the satellite tumors that grow away from the original tumor. Being able
to track down these runaway cancers could be huge.
Food and Drug Administration (FDA) for the ﬁrst time approved a single treatment that can intelligently target cancer cells while leaving healthy ones alone, and simultaneously stimulate the immune system to ﬁght the cancer itself. (source)